XmAb®5574, An Fc Engineered Humanized Anti-CD19 Monoclonal Antibody, Has Potent in Vitro and in Vivo Activities, and Has the Potential for Treating B Cell Malignancies

Autor: Lawrence, Chris E *, Zalevsky, Jonathan *, Horton, Holly *, Leung, Irene *, Chu, Seung *, Karki, Sher *, Zhukovsky, Eugene, Desjarlais, John R *, Carmichael, David F *
Zdroj: In Blood 16 November 2008 112(11):2621-2621
Databáze: ScienceDirect